ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 242 filers reported holding ICU MED INC in Q4 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $133,594 | +10.7% | 1,125 | 0.0% | 0.01% | 0.0% |
Q1 2024 | $120,735 | +7.6% | 1,125 | 0.0% | 0.01% | -45.5% |
Q4 2023 | $112,208 | -16.2% | 1,125 | 0.0% | 0.01% | -26.7% |
Q3 2023 | $133,886 | -33.2% | 1,125 | 0.0% | 0.02% | -28.6% |
Q2 2023 | $200,464 | +8.0% | 1,125 | 0.0% | 0.02% | +5.0% |
Q1 2023 | $185,580 | +4.7% | 1,125 | 0.0% | 0.02% | -9.1% |
Q4 2022 | $177,165 | -29.1% | 1,125 | 0.0% | 0.02% | 0.0% |
Q1 2022 | $250,000 | -6.4% | 1,125 | 0.0% | 0.02% | +4.8% |
Q4 2021 | $267,000 | +1.5% | 1,125 | 0.0% | 0.02% | -12.5% |
Q3 2021 | $263,000 | +13.4% | 1,125 | 0.0% | 0.02% | +14.3% |
Q2 2021 | $232,000 | +0.4% | 1,125 | 0.0% | 0.02% | -4.5% |
Q1 2021 | $231,000 | -4.1% | 1,125 | 0.0% | 0.02% | -12.0% |
Q4 2020 | $241,000 | +17.0% | 1,125 | 0.0% | 0.02% | 0.0% |
Q3 2020 | $206,000 | -0.5% | 1,125 | 0.0% | 0.02% | -10.7% |
Q2 2020 | $207,000 | -8.8% | 1,125 | 0.0% | 0.03% | -15.2% |
Q1 2020 | $227,000 | +7.6% | 1,125 | 0.0% | 0.03% | +37.5% |
Q4 2019 | $211,000 | -25.4% | 1,125 | 0.0% | 0.02% | -31.4% |
Q2 2019 | $283,000 | +5.2% | 1,125 | 0.0% | 0.04% | -2.8% |
Q1 2019 | $269,000 | 0.0% | 1,125 | 0.0% | 0.04% | 0.0% |
Q4 2018 | $269,000 | 0.0% | 1,125 | 0.0% | 0.04% | 0.0% |
Q3 2018 | $269,000 | -18.5% | 1,125 | 0.0% | 0.04% | -18.2% |
Q2 2018 | $330,000 | +16.2% | 1,125 | 0.0% | 0.04% | +18.9% |
Q1 2018 | $284,000 | +16.9% | 1,125 | 0.0% | 0.04% | +15.6% |
Q4 2017 | $243,000 | +16.3% | 1,125 | 0.0% | 0.03% | +10.3% |
Q3 2017 | $209,000 | -60.1% | 1,125 | -79.5% | 0.03% | -61.3% |
Q2 2015 | $524,000 | +2.7% | 5,475 | 0.0% | 0.08% | +10.3% |
Q1 2015 | $510,000 | +13.8% | 5,475 | 0.0% | 0.07% | +15.3% |
Q4 2014 | $448,000 | +40.4% | 5,475 | +10.1% | 0.06% | +34.1% |
Q3 2014 | $319,000 | +5.3% | 4,975 | 0.0% | 0.04% | +7.3% |
Q2 2014 | $303,000 | +1.7% | 4,975 | 0.0% | 0.04% | -6.8% |
Q1 2014 | $298,000 | -6.0% | 4,975 | 0.0% | 0.04% | -15.4% |
Q4 2013 | $317,000 | – | 4,975 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sandhill Capital Partners LLC | 91,082 | $20,915,000 | 3.45% |
CROWN ADVISORS MANAGEMENT, INC. | 14,000 | $3,215,000 | 3.34% |
PURA VIDA INVESTMENTS, LLC | 65,119 | $14,953,000 | 2.98% |
Lyon Street Capital, LLC | 11,105 | $2,550,000 | 2.56% |
GW&K Investment Management, LLC | 412,350 | $94,688,000 | 1.87% |
Penn Capital Management Company, LLC | 51,722 | $14,451,000 | 1.43% |
Hotaling Investment Management, LLC | 6,351 | $1,458,000 | 1.19% |
PFM Health Sciences, LP | 175,758 | $40,359,000 | 1.07% |
DIXON HUBARD FEINOUR & BROWN INC/VA | 12,430 | $2,854,000 | 1.06% |
GAM Holding AG | 90,452 | $20,769,000 | 1.05% |